These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21322521)

  • 1. Using nontraditional risk factors in coronary heart disease risk assessment.
    Lin KW; Garcia SM
    Am Fam Physician; 2011 Feb; 83(4):449. PubMed ID: 21322521
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for global CHD risk calculation: risk assessment alone does not change outcomes.
    Ham P
    Am Fam Physician; 2010 Aug; 82(3):236. PubMed ID: 20672785
    [No Abstract]   [Full Text] [Related]  

  • 3. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 4. Global risk of coronary heart disease: assessment and application.
    Viera AJ; Sheridan SL
    Am Fam Physician; 2010 Aug; 82(3):265-74. PubMed ID: 20672791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying the new cholesterol guidelines to your practice.
    Geisler SL
    JAAPA; 2001 Nov; 14(11):12-4, 17-8, 21-3. PubMed ID: 11766422
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the screening for tuberculosis in children.
    Selekman J
    Pediatr Nurs; 2006; 32(1):73-5. PubMed ID: 16572543
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimation of 10-year risk of fatal cardiovascular disease and coronary heart disease in Iceland with results comparable with those of the Systematic Coronary Risk Evaluation project.
    Aspelund T; Thorgeirsson G; Sigurdsson G; Gudnason V
    Eur J Cardiovasc Prev Rehabil; 2007 Dec; 14(6):761-8. PubMed ID: 18043296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How to prevent 500,000 heart attacks a year. Widespread screening for CVD could pinpoint who's vulnerable.
    Duke Med Health News; 2006 Nov; 12(11):1, 11. PubMed ID: 17225301
    [No Abstract]   [Full Text] [Related]  

  • 9. Should high sensitive C-reactive protein measurement be included in health screening packages?
    Hawkins RC; Leong L
    Singapore Med J; 2006 Oct; 47(10):837-40. PubMed ID: 16990957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of C-reactive protein as a predictor of vascular risk.
    Katrinchak C; Fritz K
    J Am Acad Nurse Pract; 2007 Jul; 19(7):335-40. PubMed ID: 17680898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raising awareness of women and heart disease--women's hearts are different.
    Herrmann C
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):251-63. PubMed ID: 18644507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AHA and ACC outline approaches to coronary disease risk assessment.
    Morey SS
    Am Fam Physician; 2000 Apr; 61(8):2534, 2537-8, 2541-2. PubMed ID: 10794587
    [No Abstract]   [Full Text] [Related]  

  • 13. Patient-centric colorectal cancer screening improvement strategies.
    Sewitch M
    Arch Intern Med; 2010 Jun; 170(12):1088-9. PubMed ID: 20585083
    [No Abstract]   [Full Text] [Related]  

  • 14. Should physicians measure high-sensitivity C-reactive protein levels to assess coronary heart disease risk?
    Alpert JS
    Am J Med; 2009 May; 122(5):405-6. PubMed ID: 19375543
    [No Abstract]   [Full Text] [Related]  

  • 15. Age and time need not and should not be eliminated from the coronary risk prediction models.
    Vasan RS; D'Agostino RB
    Circulation; 2005 Feb; 111(5):542-5. PubMed ID: 15699273
    [No Abstract]   [Full Text] [Related]  

  • 16. American Heart Association guidelines for prevention of pediatric cardiovascular disease.
    Kash IJ
    J Pediatr; 2004 Apr; 144(4):552; author reply 552-3. PubMed ID: 15069413
    [No Abstract]   [Full Text] [Related]  

  • 17. Importance of a patient's personal health history on assessments of future risk of coronary heart disease.
    Mainous AG; Everett CJ; Player MS; King DE; Diaz VA
    J Am Board Fam Med; 2008; 21(5):408-13. PubMed ID: 18772295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of coronary heart disease and the National Cholesterol Education Program.
    Kuller LH
    Circulation; 2006 Feb; 113(5):598-600. PubMed ID: 16461829
    [No Abstract]   [Full Text] [Related]  

  • 19. An assessment of the new lipid screening guidelines.
    Steiner MJ; Brown WD; Liles E
    Pediatrics; 2008 Oct; 122(4):904-5; author reply 906-7. PubMed ID: 18829821
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for chlamydia screening made feasible by new tests.
    Golden WE; Gibson-Reed C; Wells C
    J Ark Med Soc; 2002 Nov; 99(5):152-3. PubMed ID: 12434624
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.